Community Health Systems
Runs acute-care hospitals and outpatient sites through local operating subsidiaries.
Something off on this page? Send us feedback.
Profile
Owns, leases, and operates acute-care hospitals, physician practices, emergency, surgery, imaging, cancer, occupational medicine, and ambulatory surgery sites. Revenue depends on government programs, private insurers, and patient volumes, while portfolio pruning has made the footprint smaller and more focused.
Owns, leases, and operates general acute-care hospitals and related outpatient facilities through indirect subsidiaries. Services span emergency care, surgery, critical care, internal medicine, obstetrics, diagnostics, psychiatric care, rehabilitation, physician practices, urgent care, imaging, cancer care, occupational medicine, and ambulatory surgery.
Reports one hospital-operations segment, with revenue generated from government programs, managed-care plans, other third-party payors, and patients. The footprint is concentrated in the United States, with meaningful exposure to non-urban local markets and selected regional networks rather than a broad international platform.
Uses standardized operating processes, patient-safety programs, physician recruitment support, and local market coordination to run smaller community healthcare systems. Reimbursement rules, labor availability, outpatient migration, compliance obligations, and divestiture-driven portfolio pruning shape the business.
Company facts
Key statistics
Year to date −5.3% · Average volume (30d) 1.7M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Jul 27, 2026 | Truist Financial | Target | $3.75 | $3.25 | ||
| Jul 24, 2026 | UBS | Reiterate | Neutral | $3.70 | $3 | |
| Jul 23, 2026 | Barclays | Reiterate | Underweight | $3 | $2.50 | |
| Jul 14, 2026 | Truist Financial | Target | $3 | $3.75 | ||
| Jul 8, 2026 | Barclays | Downgrade | Equal Weight | Underweight |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026Q2 FY26 | −$0.10 | −$0.19 | −83.4% | $2.89B | $2.83B | −2.1% | −13.66% |
| Apr 21, 2026Q1 FY26 | −$0.11 | −$0.48 | −323.1% | $2.95B | $2.97B | +0.5% | −12.58% |
| Feb 18, 2026Q4 FY25 | −$0.20 | −$0.01 | +95.1% | $3.14B | $3.11B | −1.0% | +5.39% |
| Oct 23, 2025Q3 FY25 | −$0.28 | $1.27 | +557.4% | $2.99B | $3.09B | +3.2% | +25.77% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $3.16B | $3.13B | $3.09B | $3.11B | $12.16B | $4.06B | |
| Gross profit | $1.30B | $1.34B | $2.63B | −$4.18B | $11.75B | $2.83B | |
| Operating income | $284.0M | $512.0M | $243.0M | −$10.95B | $1.64B | $389.0M | |
| Net income | −$13.0M | $282.0M | $130.0M | $110.0M | −$610.0M | $70.0M | |
| Diluted EPS | −$0.10 | $2.09 | $0.96 | $0.82 | −$4.52 | $0.51 | |
| Gross margin | 41.1% | 42.7% | 85.1% | -134.6% | 96.6% | 69.5% | |
| Operating margin | 9.0% | 16.3% | 7.9% | -352.7% | 13.5% | 9.6% |
Fiscal years (4-quarter sums)FY21 $12.37B · FY22 $12.21B · FY23 $12.49B · FY24 $12.64B · FY25 $12.49B
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $149.0M · Total debt $10.21B · Total assets $12.18B · Shareholders' equity −$1.39B
Dividends
No dividends on record.
Ownership
Shares outstanding 141.01M · Float 110.00M · 78.0% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Castleknight Management LP | 13.38M | 9.49% | 13F | Aug 14, 2026 |
| CastleKnight Master Fund LP | 12.67M | 9.00% | 13G | May 15, 2026 |
| Apollo Management Holdings, L.P. | 11.86M | 8.41% | 13F | Aug 14, 2026 |
| BlackRock, Inc. | 10.93M | 7.75% | 13F | Aug 7, 2026 |
| Eversept Partners, LP | 7.86M | 5.58% | 13F | Aug 14, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 25, 2026 | William Norris Jennings | director | −40,000 | $2.96 |
Peers
- HCA Healthcare
Broad acute-care and outpatient hospital-network rival
- Tenet Healthcare
Acute-care hospital and national ambulatory-surgery competitor
- Universal Health Services
Hospital operator with acute-care and behavioral-health overlap
- Ardent Health
Mid-sized-market acute-care and outpatient network peer
- Surgery Partners
Focused outpatient-surgery and surgical-hospital rival
- Encompass Health
Large inpatient-rehabilitation hospital operator
- Acadia Healthcare
Pure-play behavioral-health facility competitor
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Community Health Systems | $2.94 | +0.17% | $413.2M | — | — | 0.0 | −9.8% |
| HCA Healthcare | $417.82 | −0.00% | $90.46B | 14.0 | 13.6 | 1.2 | +8.7% |
| Tenet Healthcare | $266.80 | −0.05% | $21.48B | 10.3 | 13.0 | 1.0 | +6.8% |
| Universal Health Services | $172.00 | +0.09% | $10.39B | 7.0 | 7.4 | 0.6 | +8.3% |
| Ardent Health | $10.96 | −0.18% | $1.57B | 19.9 | 9.9 | 0.2 | −1.4% |
| Surgery Partners | $13.40 | −2.12% | $1.79B | — | 31.5 | 0.5 | +2.8% |
| Encompass Health | $120.85 | 0.00% | $11.99B | 19.7 | 18.9 | 1.9 | +9.6% |
| Acadia Healthcare | $28.55 | −0.04% | $2.66B | — | 17.2 | 0.8 | −0.4% |
| Median | 14.0 | 13.6 | 0.8 | +6.8% |









